In a preliminary findings of a study presented at the annual meeting of the American Society of Clinical Oncology, a simple blood test may be able to detect lung cancer in its early stages, which would represent a promising strategy to improve survival rates, researchers said on Sunday.
The two-year survival rate is only about 15 % mainly because the disease, which kills 1.3 people globally a year is often diagnosed in advanced stages.
Preliminary findings of the study further suggests, that a specific genetic profile for lung cancer is present in the blood and can be detected with 88 % accuracy. The blood-based lung cancer genetic fingerprint is suitable to identify the disease and predict its occurrence within two years.